To face the challenge of the bio-inputs market, Bionat Biological Solutions invests in new products based on fungi and bacteria. Around R$ 40 million was allocated to the bacteria factory, one of the most modern in Brazil, with the capacity to treat 35 million hectares with its exclusive products, unique in the market. Among the technologies, there is the innovation for the control of the sugarcane weevil and coffee borer and for the total control of caterpillars at any stage of development. Bionat's action helped the Essere Group to gross over R$ 530 million in 2024, a growth of 23% compared to 2023, an extremely positive result because 2024 was a difficult year for agribusiness.